- Home
- NHTC vs IKNA Comparison
NHTC vs IKNA Comparison
Compare NHTC & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- IKNA
- Stock Information
- Founded
- NHTC 1988
- IKNA 2016
- Country
- NHTC United States
- IKNA United States
- Employees
- NHTC N/A
- IKNA N/A
- Industry
- NHTC Diversified Commercial Services
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- NHTC Miscellaneous
- IKNA Health Care
- Exchange
- NHTC Nasdaq
- IKNA Nasdaq
- Market Cap
- NHTC 56.0M
- IKNA 61.8M
- IPO Year
- NHTC 1995
- IKNA 2021
- Fundamental
- Price
- NHTC $5.00
- IKNA $1.13
- Analyst Decision
- NHTC
- IKNA Buy
- Analyst Count
- NHTC 0
- IKNA 2
- Target Price
- NHTC N/A
- IKNA $3.00
- AVG Volume (30 Days)
- NHTC 19.3K
- IKNA 97.6K
- Earning Date
- NHTC 04-30-2025
- IKNA 05-08-2025
- Dividend Yield
- NHTC 16.00%
- IKNA N/A
- EPS Growth
- NHTC N/A
- IKNA N/A
- EPS
- NHTC 0.04
- IKNA N/A
- Revenue
- NHTC $42,749,000.00
- IKNA N/A
- Revenue This Year
- NHTC N/A
- IKNA N/A
- Revenue Next Year
- NHTC N/A
- IKNA N/A
- P/E Ratio
- NHTC $124.96
- IKNA N/A
- Revenue Growth
- NHTC N/A
- IKNA N/A
- 52 Week Low
- NHTC $4.02
- IKNA $0.97
- 52 Week High
- NHTC $7.40
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- NHTC 51.78
- IKNA 43.57
- Support Level
- NHTC $4.88
- IKNA $1.22
- Resistance Level
- NHTC $5.03
- IKNA $1.29
- Average True Range (ATR)
- NHTC 0.10
- IKNA 0.09
- MACD
- NHTC 0.01
- IKNA -0.01
- Stochastic Oscillator
- NHTC 65.22
- IKNA 23.33
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.